By Stephen Bourdeau on 27/10/09 at 10:10 pm
The World Anti-doping Agency’s 2010 List of Prohibited Substances and Methods is now available. This List will go into effect on January 1, 2010. The 2010 List offers a number of changes compared to the 2009 List. In particular, the status of salbutamol and salmeterol, two beta-2 agonists, has changed.
According to the WADA website, the 2010 List reflects the latest scientific advances and offers a number of noteworthy changes compared to the 2009 List:
The status of salbutamol, a beta-2 agonist, will change. Therapeutic use of inhaled salbutamol will not be prohibited as of January 1, 2010. If the urinary concentration is above 1,000 nanograms per millilitre, there will be a presumption that the substance was not taken by inhalation and the athlete will have the burden to demonstrate through a controlled pharmacokinetic study that the level found in his urine was the result of therapeutic inhaled use.
T/E Ratio Follow-Up
No further collections or analyses will be required in cases where the testosterone to epitestosterone (T/E) ratio is greater than 4 and an isotope ratio mass spectrometry (IRMS) test or any other reliable analytical method has not revealed evidence of exogenous administration of a prohibited substance.
Pseudoephedrine will be reintroduced to the List and will be prohibited above 150 micrograms per millilitre.
To consult the 2010 List, the 2010 Monitoring Program, a summary of modifications, a document providing additional information in regards to the reintroduction of pseudoephedrine, as well as a Q&A on major changes, visit the WADA website at http://www.wada-ama.org/en/.
The updated version of the ISTUE will specify what the declaration of use exactly consists of and will clarify the TUE process. The ISTUE and its related documentation will be available in November. “
If you have any questions regarding Anti-doping, please contact Leslie Buchanan, ITU’s Anti-doping Director at firstname.lastname@example.org